Sheila Antrum
Director at ITGR
Board
About Sheila Antrum
Sheila Antrum, 66, has served as an independent director of Integer Holdings Corporation since 2021. She is Senior Vice President and Chief Operating Officer at UCSF Health, overseeing system-wide operations including nursing, clinical services, facilities, supply chain, major construction, pharmacy, women’s services and perioperative services; she also serves as President of Adult Services since 2015, with prior leadership roles in nursing and patient care, and ambulatory operations at UC San Diego Medical Center . The Board determined she is independent under NYSE listing standards .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| UCSF Health | SVP & Chief Operating Officer; President, Adult Services | At UCSF since 2007; President role since 2015 | Oversees strategic implementation of finances, quality, safety; broad operational leadership across adult inpatient enterprise |
| UCSF Medical Center & UCSF Benioff Children’s Hospital | Chief Nursing & Patient Care Services Officer | 2007–2015; 2019–2020 | Nursing and patient care leadership across multiple facilities |
| UC San Diego Medical Center | Chief of Ambulatory Operations | 2003–2007 | Ambulatory operations leadership |
| Various hospitals (CA, CT, MD, PA) | Operations, administrative, clinical roles | Prior to 2003 | Multi-facility healthcare operations experience |
External Roles
| Company | Role | Committees | Dates |
|---|---|---|---|
| FIGS, Inc. | Director | Audit; Nominating & Corporate Governance | Current |
Board Governance
- Independence: Independent director; Board has 9 of 10 nominees independent and a non-executive independent Chair .
- Committee memberships: Audit; Compensation & Organization; Technology Strategy .
- Committee activity: Audit (8 meetings in 2024); Compensation & Organization (6); Technology Strategy (4) .
- Attendance: Board held 8 meetings in 2024; each director attended at least 75% of Board and committee meetings; 100% Board attendance at the 2024 annual meeting .
- Executive sessions: Independent directors meet in executive session regularly; presided by the independent Board Chair .
Fixed Compensation
| Component | Amount | Notes |
|---|---|---|
| Cash retainer | $80,000 | Standard non-employee director cash retainer |
| Audit Committee member fee | $10,000 | Additional cash for Audit Committee members |
| Total cash earned (2024) | $90,000 | As reported for Antrum |
| Equity retainer (RSUs) | $179,924 | Grant-date fair value; standard director equity retainer is $180,000 ($240,000 for Chair) |
| Total director compensation (2024) | $269,924 | Cash plus stock awards |
| Vesting schedule (2024 director RSUs) | N/A | Grants on May 22, 2024; vest in four equal installments on the 3-, 6-, 9-month anniversaries and on May 20, 2025 |
Performance Compensation
| Equity Type | Grant Date | Vesting/Performance | Target/Payout Details |
|---|---|---|---|
| Time-based RSUs (Director equity) | May 22, 2024 | Service-based vesting in four equal installments as noted above | No performance metrics attached to director RSU awards |
Integer prohibits hedging and pledging by directors, executive officers, and associates, supporting alignment with shareholders .
Other Directorships & Interlocks
| Entity | Nature | Potential Interlock/Conflict |
|---|---|---|
| FIGS, Inc. | Public company board; Audit and Nominating & Governance committees | No related-person transactions disclosed by Integer in 2024; no conflicts noted in proxy . |
Expertise & Qualifications
- Health care industry knowledge; executive leadership; manufacturing and operations; risk management; human capital management; health, safety and environment; technology/product development leadership (per Board skills matrix) .
- Not designated an Audit Committee financial expert (Hobby, Hinrichs, Spence are designated) .
Equity Ownership
| Holder | Shares Beneficially Owned | RSUs Issuable ≤60 Days | Percent of Class |
|---|---|---|---|
| Sheila Antrum | 8,588 | 370 | <1% (Company table) |
| Shares outstanding (reference) | 34,889,876 | — | — |
| Director stock ownership guideline | ≥6,000 shares within five years; each director has achieved guideline | — | — |
| Hedging/pledging | Prohibited by policy | — | — |
Governance Assessment
- Board effectiveness: Active engagement via three committees, regular executive sessions, robust evaluation processes, and independent Chair structure support oversight quality and risk management .
- Independence & attendance: Independent status; strong attendance benchmarks (≥75% for each director; 100% attendance at annual meeting) bolster reliability and accountability .
- Compensation alignment: Director pay mix balanced between cash and equity; RSUs are service-based without performance metrics, consistent with market norms; anti-hedging/pledging and director ownership guidelines enhance alignment .
- Conflicts/related party: No related-person transactions in 2024; Section 16 reports were timely, reducing governance risk .
- Shareholder signals: Say-on-pay approval ~98% indicates broad investor support for executive compensation design and governance practices .
RED FLAGS
- None disclosed specific to Ms. Antrum: no pledging/hedging, no related-party transactions, attendance thresholds met, and independence affirmed .